Gallic acid induces ferroptosis in hepatocellular carcinoma cells by inhibiting SLC7A11 and GPX4 expression and blocking the Wnt/β-catenin pathway, highlighting its potential as a therapeutic agent for HCC. Here, SLC7A11 is linked to hepatocellular carcinoma.